Latest Breaking News On - Neoleukin therapeutics - Page 1 : comparemela.com

Neoleukin Therapeutics (NASDAQ:NLTX) Stock Price Up 6 5%

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report) was up 6.5% during trading on Thursday . The stock traded as high as $34.00 and last traded at $33.59. Approximately 51,187 shares traded hands during mid-day trading, an increase of 2% from the average daily volume of 50,104 shares. The stock had previously closed at $31.55. […]

Neoleukin therapeutics company profileExchange commissionNeoleukin therapeutics incNeoleukin therapeuticsGet free reportCapital partnersFree reportNeoleukin therapeutics daily

Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates

Neurogene Reports First Quarter 2024 Financial Results and Highlights Recent Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRachel mcminnHuman research ethics committeeNeurogene incAmerican society of geneDrug administrationExchange commissionResearch development rd expensesAustralian therapeutic goods administrationChief executive officerRecent highlightsAmerican societyCell therapyAnnual meetingAnnual goldman sachs global healthcare conferenceInternational rett syndrome foundation

TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

United statesLyell immunopharmaNapajen pharmaCellectar biosciencesFred hutchBristol myers squibbSeattle translation tumor researchSyndax pharmaceuticalsLymphoma societySerplus technologyNational cancer instituteSpecialized centerGeneron corporationResearch awardTranslational research fellowshipAmerican association for the advancement of science

Neoleukin Therapeutics (NASDAQ:NLTX) Trading Down 1 5%

Neoleukin Therapeutics (NASDAQ:NLTX) Trading Down 1 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Kestra private wealth servicesWalleye capitalShay capitalNeoleukin therapeutics incRenaissance technologiesGoldman sachs group incNeoleukin therapeutics company profileNeoleukin therapeuticsGet free reportSachs groupPrivate wealth servicesNeoleukin therapeutics daily

Neoleukin Therapeutics (NASDAQ:NLTX) Shares Up 0 9%

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX – Get Free Report)’s stock price shot up 0.9% on Tuesday . The company traded as high as $32.26 and last traded at $32.00. 46,582 shares changed hands during trading, a decline of 7% from the average session volume of 50,104 shares. The stock had previously closed at $31.70. Neoleukin Therapeutics […]

Kestra private wealth servicesWalleye capitalNeoleukin therapeutics incVirtu financialHightower advisorsNeoleukin therapeuticsGet free reportTower advisorsStreet groupPrivate wealth servicesNeoleukin therapeutics dailyNasdaq nltx